fashion -WSS

fashion

author：Wikipedia 2025-09-29 19:59:34 - browse：36

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicaid rebukes states for mistakenly disenrolling children

WSS

What drug price negotiations mean for Medicare Part D

Covid hospitalizations on the rise, Humana says

Snackable artificial intelligence, expert AI, and the pharma industry

340B reform proposal comes out of Senate working group

NIH nominee Bertagnolli will get October confirmation hearing

Snackable artificial intelligence, expert AI, and the pharma industry

knowledge

fashion

explore

Medical leaders decry Supreme Court decision on affirmative action

The Biogen Aduhelm mess could happen again

Bright Health sells Medicare Advantage business to Molina

Top private equity targets in 2023: cardiology, clinical trials, lasers

How one medical school became remarkably diverse

Illumina names Agilent executive as new CEO

Hollywood unions extend contract negotiations for actors

Stem cell treatment guidelines are released by FDA

Bright Health sells Medicare Advantage business to Molina

House transparency, PBM reform bill gains bipartisan support

entertainment

Bernie brings in new pharma CEOs to talk drug prices

Global cancer cases to surge 77% by 2050, WHO report says

The 10 drugs up first for Medicare price negotiation

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

What American doctors can learn from their Israeli counterparts

Wikipedia

knowledge

focus

hotspot